Bayesian modelling for COVID-19 seroprevalence studies

Por um escritor misterioso

Descrição

Bayesian modelling for COVID-19 seroprevalence studies
Viruses, Free Full-Text
Bayesian modelling for COVID-19 seroprevalence studies
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Bayesian modelling for COVID-19 seroprevalence studies
Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study - The Lancet Infectious Diseases
Bayesian modelling for COVID-19 seroprevalence studies
Adjusting COVID-19 seroprevalence survey results to account for test sensitivity and specificity
Bayesian modelling for COVID-19 seroprevalence studies
Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys
Bayesian modelling for COVID-19 seroprevalence studies
Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences
Bayesian modelling for COVID-19 seroprevalence studies
Improving local prevalence estimates of SARS-CoV-2 infections using a causal debiasing framework
Bayesian modelling for COVID-19 seroprevalence studies
Explicit modeling of antibody levels for infectious disease simulations in the context of SARS-CoV-2 - ScienceDirect
Bayesian modelling for COVID-19 seroprevalence studies
Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels
Bayesian modelling for COVID-19 seroprevalence studies
Dynamic parameterization of a modified SEIRD model to analyze and forecast the dynamics of COVID-19 outbreaks in the United States
Bayesian modelling for COVID-19 seroprevalence studies
Substantial underestimation of SARS-CoV-2 infection in the United States
Bayesian modelling for COVID-19 seroprevalence studies
Adjusting COVID-19 seroprevalence survey results to account for test sensitivity and specificity
de por adulto (o preço varia de acordo com o tamanho do grupo)